New! View global litigation for patent families

WO1989009067A1 - Blood processing apparatus - Google Patents

Blood processing apparatus

Info

Publication number
WO1989009067A1
WO1989009067A1 PCT/GB1989/000318 GB8900318W WO1989009067A1 WO 1989009067 A1 WO1989009067 A1 WO 1989009067A1 GB 8900318 W GB8900318 W GB 8900318W WO 1989009067 A1 WO1989009067 A1 WO 1989009067A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
vessel
means
wall
fluid
side
Prior art date
Application number
PCT/GB1989/000318
Other languages
French (fr)
Inventor
Andrew Gunn
Ian David Cameron
Original Assignee
Iatros Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/10Ultra-violet radiation

Abstract

The present invention relates to the sterilisation (in the sense of rendering free from cells or organisms capable of division e.g. lymphocytes, protozoans, bacteria, viruses) of blood or other fluids. The present invention provides an apparatus (1) for use in the ultraviolet irradiation of the fluid (8), which comprises a vessel (2) having side walls (4) substantially transparent to ultraviolet radiation of an effective inactivating wavelength; a turning vessel support (3) for supporting and allowing said vessel to turn on said support which is driven (23) so as to directly or indirectly turn the vessel on the support. U.V. irradiation means are provided for irradiating at least part of the turning vessel (2). In use of the apparatus a thin layer (9) of the fluid (8) adjacent the wall surface (10) of the side wall (4) is carried round past the ultraviolet irradiation means (7) and sterilised thereby and mixed with the main body of said fluid (8). The present invention also provides a method of inactivating undesired microorganisms in a biological fluid (8) in an apparatus (1) of the invention.

Description

BLOOD PROCESSING APPARATUS

The present invention relates to the sterilisation (in the sense of rendering free from cells or organisms cap¬ able of division e.g. lymphocytes, protozoans, bacteria, viruses) of blood and blood products or other fluids i.e. fluids having a biological origin and/or for use in biological systems including for example nutrient and buffer solutions, plasma, anti-hae ophillic globulin etc. , and in particular to means suitable for use in such a procedure, enteral or parenteral or outwith the body e.g. laboratory reagents, tissue culture or micro¬ biological systems etc.

Conventionally sterilisation of human blood products is generally effected by incubation thereof at a temper¬ ature of the order of 78°C for an extended period of time of perhaps 48 to 72 hours. This procedure is however relatively time consuming and occupies substantial amounts of relatively large scale apparatus and may result in substantial loss of potency.

It is an object of the present invention to avoid or minimize one or more of the above disadvantages.

The present invention provides an apparatus suitable for use in the ultra-violet irradiation of a biological fluid, which apparatus comprises a vessel having side wall means substantially transparent to ultraviolet radiation of an effective inactivating wavlength as defined herein; a turning vessel support means formed and arranged for supporting said vessel, in use of the apparatus, and allowing said vessel to turn on said support means; a drive means formed and arranged for directly or indirectly turning said vessel on said support means; and ultra-violet irradiation means formed and arranged for irradiating at least part of a turning vessel on said support means, with ultra-violet radiation of an effective inactivating wave- length whereby in use of the apparatus a thin layer of said fluid adjacent the wall surface of said side wall means is carried round past the ultra-violet irradiation means and sterilised thereby and mixed with the main body of said fluid.

In a further aspect the present invention provides a method of inactivating undesired microorganisms in a biological fluid comprising the steps of: providing an apparatus of the invention; supporting a said vessel containing said biological fluid on said turning vessel support means; and operating said drive means for turning said vessel on said support means and said ultra-violet irradiation means for irradiating said fluid in said vessel for a period of time sufficient substantially to inactivate said undesired microorganisms therein.

Various forms of vessel turning may be used in accordance with the present invention. In general rolling of a generally tubular form of vessel is most preferred. Turning about various different axes is, however, also possible including, for example, rotation of a vessel about a generally vertical axis by supporting the vessel on a rotating turntable. In this case in particular it will be appreciated that the turning speed is desirably selected so that it is sufficiently fast to provide a reasonable rate of mixing between the main body of the fluid and the thin layer adjacent to the outer side wall surface, and generally not so fast as to provide significant centrifugal separation of the fluid components and stratification thereof. Conveniently turning is effected at from 10 to 250 r.p.m.

It will be appreciated that the vessel may be only partly filled with the fluid undergoing irradiation or may be substantially completely filled so that at any given stage during irradiation the thin layer of fluid adjacent the wall surface of the side wall means may be simply in the form of an outer zone of an extended body of the fluid, or in the case of a partly filled rolling vessel, a discretely formed film the componentsof which are constantly being exchanged with the main body of fluid as rolling proceeds.

Any U.V. radiation known to be effective in inactivating microorganisms may be used in the apparatus and method of the invention. Suitable U.V. radiation sources include those producing radiation in the wavelength range from 100 to 400 nm preferably from 200 to 350 nm, for example UVA at approximately 320 to 400 nm, UVB at approximately 310 nm and UVC at approximately 254 nm.

Particular lamp sources which may be mentioned include those available from GTE Sylvania Ltd. of Charlestown, Shipley, West Yorkshire, Thorn EMI of Enfield, Middlesex and Philips Lighting of Croydon, Surrey, all in England.

The duration of irradiation required will depend on various factors such as the intensity, disposition, and number of sources used, the transmission characteris¬ tics of the vessel side wall material, the vessel configuration and hence the mixing efficiency therein and the surface area of the thin layer of fluid adjacent the vessel side wall, and the volume and nature of the fluid being treated. The required duration may however be readily determined by simple trial and error using suitable techniques known in the art for assessing inactivation of the relevant microorganisms and further details are provided hereinbelow. In general the duration will conveniently be in the range from 2 to 60 minutes, preferably from 5 to 30 minutes, e.g. 15 minutes, and the radiation sources are chosen and arranged, 67

-4-

to provide an effective inactivating dosage of U.V. radiation within such a period.

It should also be noted that the present invention also includes within its scope indirect inactivation of microorganisms whereby a photoactivatable drug is incorporated in the fluid, said drug being converted from a non-inactivating form into a microorganism inactivating form by U.V. irradiation. One example of a photoactivatable drug of this type that may be mentioned is a psoralen e.g. 8-methoxy psoralen which upon exposure to U.V.-A radiation of 320 to 400 nm wave¬ length becomes capable of forming photoadducts with DNA in lymphocytes thereby inactivating these.

Various forms of vessel may be used in the apparatus and method of the invention including rigid or semi¬ rigid, generally structurally self-supporting - at least when filled with the fluid, bottles as well as generally flexible bags. In the latter case, especially when these are only partly filled there will generally be required a significantly higher degree of support during rolling. Such bags may however" be more convenient due to their more or less collapsible nature which facilitates storage, packing and safety in transfusion.

In a further aspect the present invention provides a vessel for use in the apparatus and method of the invention which vessel''comprises a generally tubularbag having side wall means substantially transparent to said ultra-violet radiation, and, advantageously, side wall support means formed and arranged for supporting said side wall means, at least during an ultra-violet irradiation phase, so that said vessel has a generally cylindrical form for rolling of the vessel during a said irradiation phase, whereby in use of the apparatus an extended thin layer of said fluid adjacent a side wall surface of said side wall means may be exposed to an effective sterilising dosage of ultra-violet irradiation and said thin layer is substantially mixed with the main body of fluid in the vessel as said vessel is rolled.

The side wall support means may be of any suitable form and may be formed integrally with the side wall means e.g. as corrugations formed in the side wall means which may for example, extend circumferentially, axially, or obliquely with respect to the central rotational axis of the vessel and which have the advantage of increasing mixing during rolling of the vessel. The side wall support means may also be in the form of a separately formed structure engagable with the side wall means so as substantially to support the bag when substantially filled with fluid, in a generally cylindrical form during rolling of the vessel. The side wall support means is conveniently formed and arranged so as to be detachably engagable with the bag side wall means to minimize the costs of individual biological fluid containers by enabling each support means to be used with a large number of bags.

Such detachable support means may have any suitable form and could for example be in the form of a generally tubular self-supporting structure of uv transparent material or a generally cylindrical cage of any convenient structural material, the radiation being allowed to pass between the spaced apart elements of the cage.

In a preferred aspect the present invention provides a vessel suitable for use in the ultra-violet irradiation of a biological fluid which vessel is generally cylin¬ drical for rolling in use thereof during irradiation of a said fluid, and has corrugated side wall means sub¬ stantially transparent to ultra-violet irradiation, whereby in use of the apparatus an extended thin layer of -6-

said fluid adjacent a side wall surface of said corrugated side wall means may be exposed to an effective sterilising dosage of ultra-violet irradiation and said thin layer is substantially mixed with the main body of fluid in the vessel as said vessel is rolled.

Thus with the present invention substantially complete and effective sterilisation of a biological fluid so as to inactivate one or more of bacteria, protozoa, including plasmodium-the species responsible for malaria, trypanosomes, lymphocytes, and the like, by means of ultra-violet irradiation can be achieved quickly and economically without significant risk of impairing the functional properties of the fluid. Other microorganisms that may be inactivated to a greater or lesser degree include viruses, both DNA-type e.g. herpes simplex virus, and RNA type such as Human Immunodeficiency Virus, and pico-RNA viruses such as Coxsackie viruses.

The corrugated side wall means of the preferred embodiments may be of any suitable form. Thus the corrugations may extend transversely i.e. circumferentially, or longitud¬ inally i.e. par llel to the central axis of rotation of the generally cylindrical vessel, or diagonally i.e. helically. Furthermore the corrugations may be rounded e.g. sinusoidal, or angular in their transverse cross- sectional shape. Also, especially where the vessel is of relatively flexible material such as thin silicone rubber, the corrugated wall means may be provided with support means such as ribs, rings, flanges, or the like extending across the corrugations so as to help maintain a said generally cylindrical shape at least during rolling of the vessel with said fluid therein about its central axis of rotation.

The abovementioned vessel side wall means may be made of various u.v. - transparent materials including for -7-

example silica and other u.v. - transparent glasses such as those available under the Trade Names Spectrosil and Vitreosil; silicones; cellulose products such as Cellophane (Trade Name) ; and plastics materials such as polytetrafluo.ethylene (PTFE) , fluorinatedethenepropene (FEP) , and preferably low density polyethylene (LDPE) or polyvinyl chloride (PVC) .

Further preferred features and advantages of the present invention will appear from the following detailed description given by way of example of some preferred embodiments illustrated with reference to the accompanying drawings in which:

Fig. 1 is a schematic transverse cross-section through a first apparatus of the invention with a first vessel embodiment;

Fig. 2 is a vertical longitudinal section through a similar apparatus with a second vessel embodiment;

Fig. 3 is a view corresponding to Fig. 1 of a further embodiment; Fig. 4 is a perspective side view of another embodiment;

Fig. 5 is a transverse section through a still further embodiment; and

Fig. 6 is a perspective side view of yet another embodiment.

Fig. 1 shows a u.v. irradiation apparatus 1 comprising a vessel in the form of a generally cylindrical bag 2 of silicone rubber mounted on support rollers 3 at least one of which is driven for rolling of the bag 2. The bag 2 has corrugated side wall means 4, the corrugations 5 extending lorg.tudinally parallel to the central rotational axis 6 of the bag 2. Several u.v. radiation lamps 7 are disposed above and around the bag 2 parallel to its longitudinal axis 6 for irradiation of a blood product fluid 8 contained in the bag 2 and in particular as a thin film 9 thereof is carried up around the interior side IQ of the side wall means 4 emerging from the main body 11 of the fluid 8, with corrugated side walls there is obtained a much larger effective irradiation zone with a conventional cylindrical vessel due to a shallow penetration of u.v. irradiation in blood and like fluids, thereby allowing substantially reduced processing times for sterilisation.

In order to maintain a substantially cylindrical form of the bag 2 there are desirably provided rigidifying means such as axially spaced rings 12 and/or transversely extending flanges 13 in between opposed corrugation side walls 14.

A second form of bag is shown in Fig. 2 in which like parts corresponding to those of Fig. 1 are indicated by like reference numbers. In this case the corrugations 15 extend annula ly thereby helping to maintain a generally cylindrical form of the bag 2 without the need for addition rigidifying of the bottle and also allowing axial compression or expansion of the bag and hence variation of its internal volume. In this bottle the corrugations have a pitch of about 10mm. the overall length and outside diameter of the bottle begin some 260 mm. and 50 mm. , and the side wall means having a thickness in the range of 0.6 to 0.8 mm . Figs. 3 and 4, in which like parts corresponding to those in Figs. 1 and 2 have been indicated by like reference numbers, show alternative embodiments in which the vessel 16 is in the form of a thin-walled plain tubular bag 17 of silicone rubber, provided with wall support means 18 comprising a u.v. - transparent cylindrical glass tube 19 in the embodiment of Fig. 3 and a cylindrical wire mesh cage 20 in the embodiment of Fig. 4. By this means the bag 17 can readily be rolled during an u.v. - irradiation phase whilst being fully collapsible before introduction of biological fluid 8 thereinto. Fig. 5 shows a vessel in the form of a screw top semi¬ rigid bottle 21 of Teflon PFA (perfluoroalkoxy) of 500 or 1,000 ml capacity with a wall thickness of approximately 1.5 to 2 mm. which is commercially available from Azlon Products Ltd. of London, England.

The bottle 21 is simply supported on two rollers 3, one of which 22 is drivingly engaged with an electric drive motor 23. The U.V. lamps 7 in this case are provided with reflectors 24 to maximise efficiency by concentrating radiation on the fluid 6.

The motor 23 and lamps 7 are connected to a timer and control unit 25 formed and arranged for controlling the duration of the irradiation. Advantageously the apparatus includes circuit means (not shown) for detecting and indicating lamp failure to alert the operator to the danger of incomplete irradiation should one or more lamps fail during processing.

Fig. 6 shows a generally cylindrical vessel 26 supported on a turntable 27 provided with a rotary drive 28 for rotating the vessel 26 about a generally vertical axis. A suitable UV radiation source in the form of a plurality of UVA light tubes 29 (only one shown) is disposed generally parallel to and around the vessel 26.

Example 1 - Treatment of Human Blood Venous blood (250ml) is collected from a healthy young adult into bottle (250 ml. or 500 ml. size) made of silicone rubber (Dunlop Precision Rubbers Limited of Loughborough, England, having a shape shown in Fig. 1, and containing 2,000 units of preservative-free heparin (Weddell Pharmaceuticals Ltd., London, U.K.) or other anticoagulant e.g. CPDA.

The bottle is rolled at from 10 to 250 e.g. 140 rpm for from 5 to 30 e.g. 15 minutes under several u.v. - emitting florescent tubes extending parallel to the bottle. The irradiation chamber is air cooled with a fan.

Sterilisation of the blood is monitored by one or more of the following procedures: (a) Separation of lymphocytes, culture and subsequent dosage with tritiated thymidine and subsequent liquid scintillation counting. (b) Separation of lumphotcytes, culture and examination by electron microscope (c) Separation of lymphocytes and observation of response to tissue stains.

(d) Culture of bacteria by standard laboratory methods.

(e) Growth of viruses by standard laboratory methods.

(f) Study of Protozoans by light and electron micro- scopy and by in vivo passage in an animal species.

(g) Study of biological behaviour of Blood Platelets by standard in vitro haematological techniques, e.g. behaviour in an aggregometer and after exposure to collagen, ATP etc.

Example 2 - Inactivation of Bacteria in Fluid Samples Using the apparatus of Fig. 1 the inactivation of bacteria using the apparatus and procedures of Example 1 was monitored as follows: Bacteria either Gram+ve (Staph. albus) or Gram-ve (E. coli) or spore-forming (B. subtilis) were added in concentrations 10- per mτ_ to whole blood or fluid media and submitted to rotation/spinning in the UV radiation field and samples at 5 min. intervals were shown to be killed progessively so that by 20 min. or so the blood/, edium can be shown to be sterile by normal microbiological means. Contamination in systems envisaged to be treated would in practice never approach a concentration of bacteria as high as lσ • cells ml"1

Claims

-11-CLAIMS
1. Apparatus (1) suitable for use in the ultra-violet irradiation of a biological fluid (8) , which apparatus comprises a vessel (2) having side wall means (4) substantially transparent to ultraviolet radiation of an effective inactivating wavlength as defined herein; a turning vessel support means (3) formed and arranged for supporting said vessel (2) , in use of the apparatus (1) , and allowing said vessel (2) to turn on said support means (3) ; a drive means (23) formed and arranged for directly or indirectly turning said vessel
(2) on said support means (3) ; and ultra-violet irradiation means (7) formed and arranged for irradiating at least part of a turning vessel (2) on said support means (3) , with ultra-violet radiation of an effective inactivating wavelength whereby in use of the apparatus (1) a thin layer (9) of said fluid (8) adjacent the wall surface (10) of said side wall means (4) is carried round past the ultra-violet irradiation means (7) and sterilised thereby and mixed with the main body of said fluid (8) .
2. Apparatus according to claim 1 wherein said vessel (2) is generally tubular.
3. Apparatus according to claim 2 wherein said vessel support means (3) is formed and arranged for rolling .of said vessel (2) .
4. Apparatus according to any one of claims 1 to 3 wherein is used a U.V. irradiation source (7) which produces U.V. radiation in the wavelength range from 100 to 400 nm.
5. Apparatus according to any one of claims 1 to 4 wherein is used a vessel having a said side wall means (4) of a U.V. transparent material selected from U.V. transparent glass, silicone, cellulose, and plastics materials.
6. Apparatus according to claim 6 wherein is used a plastics material selected from polytetrafluoroethylene, fluorinatedethenepropene, low density polyethylene, and polyvinylchloride.
7. Apparatus according to any one of claims 1 to 6 wherein the vessel has corrugated side wall means (4) .
8. Apparatus according to any one of claims 1 to 7 wherein said vessel has flexible side wall means (4) formed and arranged so that said vessel is substantially collapsible when empty.
9. A method of inactivating undesired microorganisms in a biological fluid (8) comprising the steps of: providing an apparatus (1) according to claim 1, supporting a said vessel (2) containing said biological fluid (8) on said turning vessel support means (3) ; and operating said drive means (23) for turning said vessel (2) on said support means (3) and said ultra¬ violet irradiation means (7) for irradiating said fluid (8) in said vessel (3) for a period of time sufficient substantially to inactivate said undesired microorganisms therein.
ιo. A vessel suitable for use in an apparatus (1) according to claim 3 which vessel comprises a generally tubular bag (3) having side wall means (4) substantially transparent to said ultra-violet radiation.
11. A vessel according to claim 10 wherein is provided side wall support means formed integrally with the side wall means (4) and comprising corrugations ' (15) formed in the side wall means (4) which extend circumferentially, axially, and/or obliquely with respect to the central rotational axis of the vessel (2) .
PCT/GB1989/000318 1988-03-29 1989-03-28 Blood processing apparatus WO1989009067A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB8807380.4 1988-03-29
GB8807380A GB8807380D0 (en) 1988-03-29 1988-03-29 Blood processing apparatus

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE1989624485 DE68924485T2 (en) 1988-03-29 1989-03-28 UV sterilization, insbs. for blood products.
KR890072212A KR950006931B1 (en) 1988-03-29 1989-03-28 Blood processing apparatus
RU2086272C1 RU2086272C1 (en) 1988-03-29 1989-03-28 Device for sterilization by ultraviolet radiation and method of sterilization by ultraviolet radiation
DE1989624485 DE68924485D1 (en) 1988-03-29 1989-03-28 UV sterilization, insbs. for blood products.
EP19890904185 EP0422007B1 (en) 1988-03-29 1989-03-28 UV sterilisation, e.g.for blood products
DK234490A DK175119B1 (en) 1988-03-29 1990-09-28 An apparatus, method and container for the treatment of biological fluids

Publications (1)

Publication Number Publication Date
WO1989009067A1 true true WO1989009067A1 (en) 1989-10-05

Family

ID=10634257

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1989/000318 WO1989009067A1 (en) 1988-03-29 1989-03-28 Blood processing apparatus

Country Status (9)

Country Link
US (1) US5133932A (en)
EP (1) EP0422007B1 (en)
JP (1) JP2787724B2 (en)
KR (1) KR950006931B1 (en)
DE (2) DE68924485T2 (en)
DK (1) DK175119B1 (en)
GB (1) GB8807380D0 (en)
RU (1) RU2086272C1 (en)
WO (1) WO1989009067A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730883A2 (en) * 1995-03-08 1996-09-11 Hans Müller UV light illuminating device of blood or skin samples
DE19640841A1 (en) * 1996-10-02 1998-05-14 Fresenius Medical Care De Gmbh Preparation of ultra-pure infusion or dialysis solution
GB2293986B (en) * 1994-10-13 1999-01-13 Iatros Ltd Method of preparing blood plasma for analysis
EP1056837A1 (en) * 1998-02-26 2000-12-06 Hemasure, Inc. Method and apparatus for irradiating a biological fluid
US6245570B1 (en) 1991-05-08 2001-06-12 Baxter International Inc. Container for irradiation of blood products
US6258319B1 (en) 1989-10-26 2001-07-10 Cerus Corporation Device and method for photoactivation
WO2007076832A1 (en) * 2005-12-23 2007-07-12 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
EP2058012A1 (en) * 2007-11-09 2009-05-13 Octapharma AG Device for virus activation in absorbent liquids
US8173066B2 (en) 2005-12-23 2012-05-08 Forschungsgemeinschaft Der Drk Blutspendedienste E.V. Method for irradiating thrombocyte concentrates in flexible containers with ultra-violet light
US8778263B2 (en) 2007-06-22 2014-07-15 Maco Pharma S.A. Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188738A (en) * 1990-08-06 1993-02-23 Steven Kaali Alternating current supplied electrically conductive method and system for treatment of blood and/or other body fluids and/or synthetic fluids with electric forces
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US5712085A (en) 1993-06-28 1998-01-27 Cerus Corporation 5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5567616A (en) * 1994-03-07 1996-10-22 Dill Instruments Apparatus for supporting and driving a rotating cylinder
DK0840624T3 (en) 1995-07-14 2007-11-05 Caf Dcf Cvba Scrl An apparatus for inactivating viral contaminants in blood products
US5730720A (en) 1995-08-18 1998-03-24 Ip Scientific, Inc. Perfusion hyperthermia treatment system and method
WO1997033629A1 (en) * 1996-03-15 1997-09-18 Ultraviolet Technologies, Inc. Ultraviolet purification of biological fluids, blood sera and other contaminated solutions
US6066489A (en) 1996-08-30 2000-05-23 Arrow International, Inc. Method for treating blood borne viral pathogens such as immunodeficiency virus
US5951509A (en) * 1996-11-22 1999-09-14 Therakos, Inc. Blood product irradiation device incorporating agitation
US6153107A (en) * 1997-08-14 2000-11-28 Asahi Kasei Kogyo Kabushiki Kaisha Process for treating development waste liquor
DE19831768A1 (en) * 1998-07-15 2000-02-17 Paa Lab Gmbh Apparatus for irradiating a liquid
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US6465799B1 (en) 1999-03-01 2002-10-15 Johnson & Johnson Vision Care, Inc. UV radiation system having materials for selectively attenuating radiation
US7879288B2 (en) 1999-03-01 2011-02-01 Johnson & Johnson Vision Care, Inc. Method and apparatus of sterilization using monochromatic UV radiation source
US6592816B1 (en) 1999-03-01 2003-07-15 Johnson & Johnson Vision Care, Inc. Sterilization system
US6312593B1 (en) * 1999-04-23 2001-11-06 Thomas R. Petrie Ultraviolet blood irradiation chamber
US7068361B2 (en) * 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US6565802B1 (en) * 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
CA2275467C (en) 1999-06-18 2004-03-02 Biophys Inc. Method and apparatus for flowing sterile fluid membranes
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US6576201B1 (en) * 2000-01-28 2003-06-10 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
US6596230B1 (en) * 2000-01-28 2003-07-22 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
EP1286996A1 (en) 2000-06-02 2003-03-05 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
WO2002047734A1 (en) * 2000-12-14 2002-06-20 Biophys, Inc. Sterilization of fluids using ultra-thin fluid membranes
US20030060747A1 (en) * 2001-05-17 2003-03-27 Fries William M. Fluid flow path for a fluid treatment system using light for the decontamination of fluid products
US6719716B2 (en) 2001-08-15 2004-04-13 Robert E. Clark Hemo-aide
US7404806B2 (en) * 2002-08-14 2008-07-29 Clark Robert E Hemo-aide
DE10152159A1 (en) * 2001-10-25 2003-05-15 Aventis Behring Gmbh A method for protein gentle cleaning of contaminated biological fluids
EP1693072A1 (en) * 2002-04-26 2006-08-23 Gambro, Inc., Apparatus and method for irradiating and mixing fluids in containers
US6797971B2 (en) * 2002-07-18 2004-09-28 Fusion Uv Systems, Inc. Apparatus and method providing substantially two-dimensionally uniform irradiation
ES2453105T3 (en) 2003-02-27 2014-04-04 Baxter International Inc. Device for calibrating a method for certifiable pathogen inactivation by irradiation in a biological fluid
CA2694169A1 (en) * 2007-08-01 2009-02-05 Caridianbct Biotechnologies, Llc Pathogen inactivation of whole blood
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
WO2005082937A3 (en) 2004-02-27 2005-11-17 Andrea Buchacher A method of providing a purified, virus safe antibody preparation
CA2614765A1 (en) * 2004-07-23 2006-01-26 Uv Light Sciences Group, Inc. Uv sterilizer
US20060052251A1 (en) * 2004-09-09 2006-03-09 Anderson David K Time release multisource marker and method of deployment
US7547391B2 (en) * 2004-11-22 2009-06-16 Energex Systems, Inc. Blood irradiation system, associated devices and methods for irradiating blood
EP2066358A1 (en) * 2006-09-26 2009-06-10 ID Biomedical Corporation of Quebec Device and methods of inactivating influenza virus and adventitious agents with ultraviolet light
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US8430968B2 (en) 2008-01-22 2013-04-30 Hydro Dynamics, Inc. Method of extracting starches and sugar from biological material using controlled cavitation
US9402866B2 (en) 2011-04-07 2016-08-02 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
DE102011112994A1 (en) * 2011-09-08 2013-03-14 Schott Ag Apparatus for sterilizing gases and / or liquids
RU2512311C1 (en) * 2013-02-21 2014-04-10 Александр Владимирович Наумов Method for food products thermostating and sterilisation
US9265876B1 (en) * 2014-10-22 2016-02-23 Hemalux Technologies LLC Systems and methods for pathogen inactivation in blood using UV irradiation while minimizing heat transfer thereto
JP2017219452A (en) * 2016-06-09 2017-12-14 株式会社日立ハイテクノロジーズ Automatic analyzer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB419929A (en) * 1933-06-13 1934-11-21 British Thomson Houston Co Ltd Improvements in and relating to systems of irradiation
EP0086738A1 (en) * 1982-02-13 1983-08-24 Georg Horstmann Apparatus for sterilising liquids or gases
DE3412143A1 (en) * 1984-03-31 1985-10-10 Biotest Pharma Gmbh Method and device for the sterilisation of cell suspensions
DE3624511A1 (en) * 1985-01-08 1987-05-07 Dresden Praecitronic Cuvette for irradiation of biological fluids by means of ultraviolet light

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE24822E (en) * 1960-05-03 Richard
GB321639A (en) * 1928-08-07 1929-11-07 Lester Almond Edblom Improved means for treating blood stream infections
US2001555A (en) * 1934-03-15 1935-05-14 Hanovia Chemical & Mfg Co Device for the irradiation of milk with ultraviolet rays
GB574803A (en) * 1943-01-05 1946-01-22 Emmet Kennard Knott Apparatus for the treatment of blood
GB639467A (en) * 1946-07-10 1950-06-28 Michel Pequignot Improved apparatus for treating fluids by radiation
US3439510A (en) * 1967-12-01 1969-04-22 Gray Ind Inc Treatment of red blood cells
US3814680A (en) * 1971-05-06 1974-06-04 Meltzer H Process and apparatus for purification of materials
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
US3894236A (en) * 1973-12-10 1975-07-08 Wayne K Hazelrigg Device for irradiating fluids
GB1450009A (en) * 1974-03-11 1976-09-22 Ziristor Ag Sterilization of a tube of material
JPS526676A (en) * 1975-07-07 1977-01-19 Ikeda Shiyouten Kk Squid luring hooks
FR2500430B1 (en) * 1981-02-26 1983-06-24 Commissariat Energie Atomique
CA1253115A (en) * 1983-09-29 1989-04-25 Extracorporeal Medical Specialties, Inc. Apparatus and methods for treating cells with radiation
JPH0252507B2 (en) * 1983-11-25 1990-11-13 Daicel Chem
JPH0359381B2 (en) * 1984-02-16 1991-09-10 Kollmorgen Tech Corp
JPH0425020B2 (en) * 1984-09-22 1992-04-28 Nitta Gelatin Kk
US4608255A (en) * 1985-01-31 1986-08-26 American National Red Cross Biocompatible method for in situ production of functional platelets and product produced thereby lacking immunogenicity
CA1324413C (en) * 1986-02-27 1993-11-16 Kyu H. Lee Disposable patient fluid irradiation chamber
US4726949A (en) * 1986-08-26 1988-02-23 Baxter Travenol Laboratories, Inc. Irradiation of blood products
US4798702A (en) * 1986-09-10 1989-01-17 Tucker Robert E Sterilizer unit for fluid media and process
DE8701221U1 (en) * 1986-10-08 1987-04-23 Hoeveler, Victor, Dr.Med., 4190 Kleve, De
DE3824647C2 (en) * 1988-07-20 1992-03-26 Wedeco Gesellschaft Fuer Entkeimungsanlagen Mbh, 4900 Herford, De

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB419929A (en) * 1933-06-13 1934-11-21 British Thomson Houston Co Ltd Improvements in and relating to systems of irradiation
EP0086738A1 (en) * 1982-02-13 1983-08-24 Georg Horstmann Apparatus for sterilising liquids or gases
DE3412143A1 (en) * 1984-03-31 1985-10-10 Biotest Pharma Gmbh Method and device for the sterilisation of cell suspensions
DE3624511A1 (en) * 1985-01-08 1987-05-07 Dresden Praecitronic Cuvette for irradiation of biological fluids by means of ultraviolet light

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461567B1 (en) 1989-10-26 2002-10-08 Cerus Corporation Device and method for photoactivation
US6680025B2 (en) 1989-10-26 2004-01-20 Cerus Corporation Device and method for photoactivation
US6258319B1 (en) 1989-10-26 2001-07-10 Cerus Corporation Device and method for photoactivation
US6696023B2 (en) 1991-05-08 2004-02-24 Baxter International Inc. Apparatus for irradiation of blood products
US6245570B1 (en) 1991-05-08 2001-06-12 Baxter International Inc. Container for irradiation of blood products
GB2293986B (en) * 1994-10-13 1999-01-13 Iatros Ltd Method of preparing blood plasma for analysis
EP0730883A3 (en) * 1995-03-08 1999-02-03 Hans Müller UV light illuminating device of blood or skin samples
EP0730883A2 (en) * 1995-03-08 1996-09-11 Hans Müller UV light illuminating device of blood or skin samples
DE19640841A1 (en) * 1996-10-02 1998-05-14 Fresenius Medical Care De Gmbh Preparation of ultra-pure infusion or dialysis solution
EP1056837A4 (en) * 1998-02-26 2003-04-02 Hemasure Inc Method and apparatus for irradiating a biological fluid
EP1056837A1 (en) * 1998-02-26 2000-12-06 Hemasure, Inc. Method and apparatus for irradiating a biological fluid
WO2007076832A1 (en) * 2005-12-23 2007-07-12 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
EP2198886A1 (en) * 2005-12-23 2010-06-23 BLUTSPENDEDIENST DER LANDESVERBÄNDE DES DEUTSCHEN ROTEN KREUZES NIEDERSACHSEN, OLDENBURG UND BREMEN G.G.m.b.H. Method for deactivating pathogens in donor blood, blood plasma or erythrocyte concentrates in flexible containers in motion
US8164073B2 (en) 2005-12-23 2012-04-24 Harald Mohr Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrates in flexible containers under agitation
US8173066B2 (en) 2005-12-23 2012-05-08 Forschungsgemeinschaft Der Drk Blutspendedienste E.V. Method for irradiating thrombocyte concentrates in flexible containers with ultra-violet light
CN101340930B (en) 2005-12-23 2012-09-05 下萨克森、萨克森-安哈特、图林根、奥登堡和不来梅德国红十字会州联合会供血服务站非营利股份有限责任公司 Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
US8525128B2 (en) 2005-12-23 2013-09-03 Blutspendedienst Der Landesverbande Des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thuringen, Oldenburg Und Bremen G.G.M.B.H. Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrates in flexible containers under agitation
US8778263B2 (en) 2007-06-22 2014-07-15 Maco Pharma S.A. Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process
US9320817B2 (en) 2007-06-22 2016-04-26 Maco Pharma S.A. Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process
EP2058012A1 (en) * 2007-11-09 2009-05-13 Octapharma AG Device for virus activation in absorbent liquids

Also Published As

Publication number Publication date Type
DK234490D0 (en) 1990-09-28 grant
JP2787724B2 (en) 1998-08-20 grant
RU2086272C1 (en) 1997-08-10 grant
DE68924485D1 (en) 1995-11-09 grant
KR950006931B1 (en) 1995-06-26 grant
US5133932A (en) 1992-07-28 grant
DE68924485T2 (en) 1996-05-30 grant
GB8807380D0 (en) 1988-05-05 grant
JPH03503730A (en) 1991-08-22 application
EP0422007B1 (en) 1995-10-04 grant
DK234490A (en) 1990-09-28 application
EP0422007A1 (en) 1991-04-17 application
DK175119B1 (en) 2004-06-07 grant

Similar Documents

Publication Publication Date Title
US4952511A (en) Photobioreactor
US4317041A (en) Multichamber photoreactor
US4755292A (en) Portable ultraviolet water sterilizer
US6190609B1 (en) Methods and apparatus for inactivating contaminants in biological fluid
US6730265B2 (en) Air UV disinfection device and method
US5496302A (en) Method for sterilizing
US3433946A (en) Ultraviolet radiation fluid sterilizer having means for discharging the fluid free of contamination
US4069153A (en) Method of destroying pyrogens
US20040022669A1 (en) Non-thermal disinfection of biological fluids using non-thermal plasma
US6986867B2 (en) Apparatus, systems and methods for processing and treating a biological fluid with light
US7081225B1 (en) Methods and apparatus for disinfecting and sterilizing fluid using ultraviolet radiation
US5922278A (en) Method and apparatus for inactivating contaminants in biological fluid
US5290221A (en) Systems for eradicating contaminants using photoactive materials in fluids like blood
US4599216A (en) Apparatus for exposure to microwaves
US5320749A (en) Apparatus for treatment of fluid media with ultraviolet irradiation
US20020168287A1 (en) Method and apparatus for rapidly sterilizing irregularly-shaped objects
US4798702A (en) Sterilizer unit for fluid media and process
US5707594A (en) Pathogen control system
US5628727A (en) Extracorporeal virioncidal apparatus
US6312593B1 (en) Ultraviolet blood irradiation chamber
US5030200A (en) Method for eradicating infectious biological contaminants in body tissues
US20030049809A1 (en) Method of inactivating microorganisms in a fluid using ultraviolet radiation
US4748120A (en) Photochemical decontamination treatment of whole blood or blood components
US20070272877A1 (en) In-Line Treatment of Liquids and Gases by Light Irradiation
US20100078574A1 (en) Ultraviolet light treatment chamber

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU DK JP KR SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1989904185

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989904185

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1989904185

Country of ref document: EP